Sio Gene Therapies to Participate in Upcoming Conferences
September 23 2021 - 7:30AM
Sio Gene Therapies Inc. (NASDAQ: SIOX), a clinical-stage company
focused on developing gene therapies to radically improve the lives
of patients with neurodegenerative diseases, announced today that
the company will participate in select upcoming investor and
scientific conferences. Details can be found below.
Cantor Fitzgerald Global Healthcare
Conference
Participation: |
Presentation |
Presenter:Date:Time: Webcast
Link: |
Pavan Cheruvu, MD, Chief
Executive OfficerMonday, September 27th 10:00 AM
EThttps://wsw.com/webcast/cantor12/siox/2117150 |
Chardan Genetic Medicines Conference
Participation: |
Presentation |
Presenter:Date:Time:
Webcast Link: |
Pavan Cheruvu, MD,
Chief Executive OfficerTuesday, October 5th9:00 AM
EThttps://wsw.com/webcast/chard9/siox/1887025 |
Alliance for Regenerative Medicine: Cell & Gene
Meeting on the Mesa
Presenter:Date:Time: |
Parag V. Meswani, PharmD, Chief Commercial OfficerOctober 12,
2021The company presentation will be available to view on-demand
throughout the entirety of the conference. Please visit Cell &
Gene Meeting on the Mesa for full information including
registration. |
About Sio Gene TherapiesSio Gene Therapies
combines cutting-edge science with bold imagination to develop
genetic medicines that aim to radically improve the lives of
patients. Our current pipeline of clinical-stage candidates
includes the first potentially curative AAV-based gene therapies
for GM1 gangliosidosis and Tay-Sachs/Sandhoff diseases, which are
rare and uniformly fatal pediatric conditions caused by single gene
deficiencies. We are also expanding the reach of gene therapy to
highly prevalent conditions such as Parkinson’s disease, which
affects millions of patients globally. Led by an experienced team
of gene therapy development experts, and supported by
collaborations with premier academic, industry and patient advocacy
organizations, Sio is focused on accelerating its candidates
through clinical trials to liberate patients with debilitating
diseases through the transformational power of gene therapies. For
more information, visit www.siogtx.com.
Contacts:
Media Josephine Belluardo, Ph.D. LifeSci
Communications(646) 751-4361jo@lifescicomms.cominfo@siogtx.com
Investors and AnalystsParag V. MeswaniSio Gene
Therapies Inc.Chief Commercial Officerinvestors@siogtx.com
Sio Gene Therapies (NASDAQ:SIOX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sio Gene Therapies (NASDAQ:SIOX)
Historical Stock Chart
From Jul 2023 to Jul 2024